ASCVD MANAGEMENT
Clinical trials for ASCVD MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new ASCVD MANAGEMENT trials appear
Sign up with your email to follow new studies for ASCVD MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smartwatch heart coach: can a wearable boost recovery from home?
Disease control Not yet recruitingThis study is testing if adding a medical-grade smartwatch to a virtual heart rehab program helps patients improve their health more than the program alone. About 216 people with heart disease will join the 13-week virtual coaching program. Some will wear the watch daily, allowin…
Matched conditions: ASCVD MANAGEMENT
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug trial aims to shrink dangerous artery plaque
Disease control Not yet recruitingThis study is testing whether an experimental drug called ABP-745 can reduce the amount of plaque buildup in the arteries of people with heart disease. Researchers will compare ABP-745 against a placebo in 200 participants over 52 weeks to see if it safely shrinks plaque. The goa…
Matched conditions: ASCVD MANAGEMENT
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New trial targets hidden genetic driver of heart disease inflammation
Disease control Not yet recruitingThis study is testing whether a drug called canakinumab can reduce dangerous inflammation in the arteries of people who have had a heart attack or stent. It specifically includes people with and without a common age-related genetic change called TET2 CHIP. Researchers will use he…
Matched conditions: ASCVD MANAGEMENT
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC